Hedgehog Pathway Inhibitors Market To Reach USD 961.7 Million By 2026 | Reports And Data
October 28, 2019 12:50 ET
|
Reports and Data
New York, Oct. 28, 2019 (GLOBE NEWSWIRE) -- High prevalence of target diseases, product launches, increasing strategic developments such as partnerships and agreements, increasing demand of painless...
Biovitrum's Project Portfolio Advances -- Pharmaceutical Project for the Treatment of Glaucoma Enters Phase I
September 13, 2005 04:16 ET
|
Biovitrum
STOCKHOLM, Sweden, Sept. 13, 2005 (PRIMEZONE) -- The glaucoma candidate drug (BVT.28949) has been internally developed within Biovitrum and the first clinical study for safety testing was entered in...